Red
Brand Name(s):Fotivda
Indication:Renal cell carcinoma (advanced) and for adult patients who are VEGFR and mTOR pathway inhibitor-naïve following disease progression after one prior treatment with cytokine therapy for advanced RCC.
Rationale:1,2,3
Considered:Feb-18
Review Date:Mar-23
Comments: